The role and mechanisms of mesenchymal stem cells regulating macrophage plasticity in spinal cord injury

Biomed Pharmacother. 2023 Dec:168:115632. doi: 10.1016/j.biopha.2023.115632. Epub 2023 Oct 6.

Abstract

Spinal Cord Injury (SCI) is a devastating neurological disorder comprising primary mechanical injury and secondary inflammatory response-mediated injury for which an effective treatment is still unavailable. It is well known that secondary inflammatory responses are a significant cause of difficulties in neurological recovery. An immune imbalance between M1/M2 macrophages at the sites of injury is involved in developing and progressing the secondary inflammatory response. Recently, Mesenchymal Stem Cells (MSCs) have shown significant therapeutic potential in tissue engineering and regenerative medicine due to their potential multidirectional differentiation and immunomodulatory properties. Accumulating evidence shows that MSCs can regulate the balance of M1/M2 macrophage polarization, suppress downstream inflammatory responses, facilitate tissue repair and regeneration, and improve the prognosis of SCI. This article briefly overviews the impact of macrophages and MSCs on SCI and repair. It discusses the mechanisms by which MSCs regulate macrophage plasticity, including paracrine action, release of exosomes and apoptotic bodies, and metabolic reprogramming. Additionally, the article summarizes the relevant signaling pathways of MSCs that regulate macrophage polarization.

Keywords: Macrophages; Mesenchymal stem cells; Microglia; Spinal cord injury.

Publication types

  • Review

MeSH terms

  • Cell Differentiation
  • Exosomes* / metabolism
  • Humans
  • Macrophages / metabolism
  • Mesenchymal Stem Cells* / metabolism
  • Spinal Cord / metabolism
  • Spinal Cord Injuries* / drug therapy